Reginald M Gorczynski

InstitutionUniversity of Toronto
AddressToronto
Canada
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 1 Covid-19 publications, with a maximum of 1 publications in July 2020
    All Publications
    Bar chart showing 201 publications over 26 distinct years, with a maximum of 19 publications in 1996
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Steele EJ, Gorczynski RM, Lindley RA, Tokoro G, Temple R, Wickramasinghe NC. Origin of new emergent Coronavirus and Candida fungal diseases-Terrestrial or cosmic? Adv Genet. 2020; 106:75-100. PMID: 33081928.
      Citations: 2     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    2. Chen Z, Ma X, Zhang J, Hu J, Gorczynski RM. Alternative splicing of CD200 is regulated by an exonic splicing enhancer and SF2/ASF. Nucleic Acids Res. 2010 Oct; 38(19):6684-96. PMID: 20558599.
      Citations: 5     Fields:    Translation:HumansAnimalsCells
    3. De Albuquerque N, Baig E, Ma X, Zhang J, He W, Rowe A, Habal M, Liu M, Shalev I, Downey GP, Gorczynski R, Butany J, Leibowitz J, Weiss SR, McGilvray ID, Phillips MJ, Fish EN, Levy GA. Murine hepatitis virus strain 1 produces a clinically relevant model of severe acute respiratory syndrome in A/J mice. J Virol. 2006 Nov; 80(21):10382-94. PMID: 17041219.
      Citations: 75     Fields:    Translation:HumansAnimalsCells
    4. Ning Q, Brown D, Parodo J, Cattral M, Gorczynski R, Cole E, Fung L, Ding JW, Liu MF, Rotstein O, Phillips MJ, Levy G. Ribavirin inhibits viral-induced macrophage production of TNF, IL-1, the procoagulant fgl2 prothrombinase and preserves Th1 cytokine production but inhibits Th2 cytokine response. J Immunol. 1998 Apr 01; 160(7):3487-93. PMID: 9531310.
      Citations: 78     Fields:    Translation:AnimalsCells
    5. Liu MF, Ning Q, Pope M, Mosmann T, Leibowitz J, Ding JW, Fung LS, Rotstein O, Gorczynski R, Levy GA. Resistance of naive mice to murine hepatitis virus strain 3 requires development of a Th1, but not a Th2, response, whereas pre-existing antibody partially protects against primary infection. Adv Exp Med Biol. 1998; 440:415-23. PMID: 9782309.
      Citations: 7     Fields:    Translation:AnimalsCells
    6. Chung S, Gorczynski R, Cruz B, Fingerote R, Skamene E, Perlman S, Leibowitz J, Fung L, Flowers M, Levy G. A Th1 cell line (3E9.1) from resistant A/J mice inhibits induction of macrophage procoagulant activity in vitro and protects against MHV-3 mortality in vivo. Immunology. 1994 Nov; 83(3):353-61. PMID: 7835959.
      Citations: 7     Fields:    Translation:AnimalsCells
    7. Chung S, Li C, Fung LS, Crow A, Gorczynski R, Cole E, Perlman S, Leibowitz J, Levy G. Role of macrophage procoagulant activity in mouse hepatitis virus (MHV) infection: studies using T cell MHV-3 clones and monoclonal antibody 3D4.3. Adv Exp Med Biol. 1993; 342:377-84. PMID: 8209757.
      Citations:    Fields:    Translation:AnimalsCells